Sign in
CompletedNo phase

Behavioral Economics to Improve Flu Vaccination Using EHR Nudges

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia and Seattle, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
80,039 people enrolled
Started
25 Sept 2023
Ended
20 May 2024
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Pre-visit patient text messaging
  • Default pended order
  • Monthly peer comparison feedback
  • High risk bidirectional pre-visit text messaging
Record updated
27 April 2025

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Other criteria

  • Patient Inclusion Criteria:
  • All patients must meet the following criteria to be eligible:
  • Age >50 years
  • A scheduled new or return (non-urgent/sick) primary care appointment at one of the study practices at the Penn Medicine, UW Medicine, or Lancaster General Hospital
  • Have not received their annual flu vaccine during the active intervention period (September- February)
  • Eligible to receive the flu vaccine; For the high risk intensification nudge, at least one of the following criteria must be met to be considered high risk and randomized to receive the intensification nudge:
  • Age ≥ 70 years
  • Living in a lower income community (lowest quartile, zip-code based)
  • Did not receive a flu vaccine in the previous calendar year
  • Self-identifies as Non-Hispanic Black; Patient Exclusion Criteria:
  • Have a documented allergy to flu vaccine
  • Have a flu vaccine exclusion modifier in Health Maintenance
  • Have opted out of research according to individual site guidelines and policies
  • Have no phone number (home or mobile) listed in their chart; Clinician Inclusion Criteria:; Clinicians must meet the following criteria to be eligible to receive peer comparison feedback:
  • Practicing physician (MD, DO) or advanced practice provider (NP, PA) with the exception of residents and fellows
  • Have a minimum patient panel of at least 50 patients, and
  • Practicing at a clinical site randomized to receive the clinic-level nudge interventions

Where in United States

  • University of Pennsylvania Health SystemPhiladelphia, United States
  • University of WashingtonSeattle, United States

About the trial

What the trial wants to find out

This study will be a multisite, cluster randomized, pragmatic trial to evaluate the effectiveness of personalized nudges to clinicians and patients, relative to a control, to increase flu vaccination rates among older adults in accordance with CDC guidelines. This will include clinician and patient level nudge interventions, with an additional, intensified nudge intervention for patients identified as high risk for not receiving a flu vaccine. Among the intervention clinics, patients will receive pre-visit text message reminders about the flu vaccine, and clinicians will receive a default pended order in the visit encounter in the EHR, along with monthly peer comparison feedback about their flu vaccine completion rate. Patients identified as high risk for noncompletion will be individually randomized to receive an additional bidirectional text message nudge or the standard text messaging.

The 3 groups in the trial

  • ControlNo study treatment, for comparison

    Clinics randomized to the control arm will receive standard of care.

  • Intervention ArmTreatment being tested

    Clinics randomized to the intervention arm will receive the toolkit of clinician and patient facing nudges. Patient nudges will be pre-visit text message reminders (standard messaging content). Clinician nudges will be monthly peer comparison feedback and default pended orders.

    Treatment: Pre-visit patient text messaging, Default pended order, and Monthly peer comparison feedback

  • High Risk Intensification ArmTreatment being tested

    Patients in the intervention clinics identified as high risk for noncompletion of the flu vaccine will be randomized 1:1 to receive the high risk intensification arm or remain in the standard intervention arm. Patients in the high risk intensification arm will receive an additional bidirectional texting component.

    Treatment: Pre-visit patient text messaging, Default pended order, Monthly peer comparison feedback, and High risk bidirectional pre-visit text messaging

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
BE IMMUNE: Behavioral Economics to IMprove and Motivate Vaccination Using Nudges Through the EHR
Publications
Record updated
27 April 2025